Applied Cell Technology Overview
- Founded
-
2013
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$806K
- Investors
-
3
Applied Cell Technology General Information
Description
Developer and distributor of patented platform technology designed to enhance cell competence. The company's technology forms genetic materials to improve the effectiveness of cryopreservation by preserving the viability and function of the spermatozoa, enabling clients to ensure significantly improved survival of stem cells, gametes and embryos after interventions.
Contact Information
Website
www.appliedcelltechnology.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Devices and Supplies
Biotechnology
Primary Office
- 1 Búza street
- Gyongyos, 3200
- Hungary
+36 (06 0) 000 0000
Applied Cell Technology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Grant | 28-Feb-2018 | $806K | Completed | Generating Revenue | ||
| 2. Early Stage VC | Completed | Generating Revenue | ||||
| 1. Early Stage VC | 01-Jan-2014 | Completed | Generating Revenue |
Applied Cell Technology Patents
Applied Cell Technology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20140093864-A1 | Increasing the viability and stress tolerance of viable biological material | Abandoned | 01-Oct-2012 | 00000000 | |
| US-20140329222-A1 | Increasing the viability and stress tolerance of viable biological material | Abandoned | 22-Nov-2005 | 000000000 | |
| ES-2500142-T3 | Increased viability and stress tolerance of viable biological material | Active | 22-Nov-2005 | 00000000 | |
| US-8278031-B2 | Increasing the viability of mammalian oocytes | Expired - Fee Related | 22-Nov-2005 | 00000000 | 0 |
| US-20090017440-A1 | Increasing the viability and stress tolerance of viable biological material | Granted | 22-Nov-2005 | A01N1/02 | 0 |
Applied Cell Technology Executive Team (4)
Applied Cell Technology Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Applied Cell Technology Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| National Research, Development and Innovation Office | Government | 000 0000 | 000000 0 | ||
| Széchenyi Equity Fund Manager | Venture Capital | Minority | 000 0000 | 000000 0 | |
| PortfoLion | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |